Increasing California's Capacity to Partner in Global Breast

Institution: Beckman Research Institute of the City of Hope
Investigator(s): Kimlin Ashing, Ph.D. -
Award Cycle: 2012 (Cycle 18) Grant #: 18MB-0001 Award: $25,000
Award Type: Joining Forces Conference Award
Research Priorities
Community Impact of Breast Cancer>Disparities: eliminating the unequal burden of breast cancer



Final Report (2012)

International scientific collaboration in biomedical and population research is a rapidly growing trend. The goal of this 3-day conference is to share knowledge, experiences and resources relevant to breast cancer in Chinese populations among diverse scientists, clinicians, advocates, and public health and supportive care professionals who are based in California, the U.S. and Internationally to inform optimal prevention, clinical and supportive care practices; and promote international clinical, therapeutic development and population studies, and community-participatory programs and research. Such efforts are particularly important in California where Asians are the second fastest growing population (14%) and their representation among those affected by breast cancer is increasing. This conference will: 1) facilitate dialog and relationship building, expand alliance, and exchange knowledge and information between breast cancer advocates, medical experts and researchers from multiple fields such as medicine, nursing, basic biomedical and population science, psychology, social work and public health who are concerned about breast cancer among women of Chinese ancestry; 2) Disseminate research approaches, findings, methodology, measurements from diverse fields to stimulate new hypotheses for multi-disciplinary scientific collaborations and translational research; 3) Provide updates on breast cancer screening, prevention, diagnostics, genetics and therapeutics advancements in California, nationally and internationally; 4) Establish a platform for practical and successful community participatory research and program partnerships locally and internationally; and 5) Build capacity, training, leadership, communication and supportive care practices among professionals and advocates. In summary, this global conference is a unique opportunity with paramount significance to the scientific, clinical and advocacy communities in California. The groundbreaking conference also takes place at a historic point in time where we are moving towards an era of personalized medicine and genomics. At this conference we will share the new tools of biospecimen, genetics, clinical and translational research, and generate international collaborations to give added impetus to the existing concerted global drive for breast cancer prevention and risk reduction, screening and surveillance, accurate diagnosis, targeted and curative treatment, and optimal survivorship care.

The structure of this 3-day conference includes 7 diverse breast cancer experts as keynote speakers; in addition there will be 4 plenary sessions, 8 breakout sessions, and 8 workshops for clinicians, researchers, advocates, community leaders. Over 250 participants including researchers (20%), clinicians (30%), public health workers/cancer educators (10%), advocates (30%), and survivors (10%) from California and around the world will attend.

Breast cancer advocates in California, other regions of the U.S. including Texas and New York are at the heart of this conference. In fact, the conference idea belongs to the advocacy community who initiated partnership with the scientific community to join in this innovative conference. This conference titled “The Global Chinese Breast Cancer Alliance Conference (GCBCA)” to be held in Los Angeles is a collaboration project between Dr. Ashing-Giwa of City of Hope and Lucy Young of Herald Cancer Association (HCA), a non-profit grass root organization that provides services to underserved Chinese cancer patients and their families. HCA has a growing presence in Los Angeles since 2002. HCA is firmly committed to activating the Chinese-American community with regards to research engagement and research participation in clinical, biospecimen banking, and behavioral studies. Ms. Young has successful scientific-community partnerships in California, nationally and internationally. She will use this Conference as a platform to expand her community education on the role and importance of research in the Chinese-American and Chinese community to increase their research engagement and participation. Further, several of the workshop focusing on capacity building and training for the advocacy community will be conducted by advocate leaders in California, Texas and Asia.